Ingram Entertainment Inc.:企業の戦略的SWOT分析

◆英語タイトル:Ingram Entertainment Inc. - Strategic SWOT Analysis Review
◆商品コード:DATA904C15805
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ingram Entertainment Inc. – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Ingram Entertainment Inc. (Ingram) is a distributor of home entertainment products. The company’s product portfolio comprises video game hardware and software, DVDs, audio books and accessories. Ingram also offers marketing tools, online tools, publications, advertising placements, creative services and VM/category management. The company sells its products online through its web portal, accessingram.com. Ingram sells products through internet retailers, electronics and video game stores, drugstores, mass merchants, truck shops, travel centers, convenience stores, supermarkets, and specialty stores such as book stores, computer stores, home electronics stores, libraries, music stores, rent-a-center stores, restaurants, tanning salons, traditional brick-and-mortar video rental and sell-through stores, and vending machines. The company has distribution centers in Baltimore, Memphis, Chicago, Portland, Orange and Toledo. Ingram is headquartered in La Vergne, Tennessee, the US.

Ingram Entertainment Inc. Key Recent Developments

Jul 31,2018 DBI Beverage announces top leadership changes, effective January 1, 2019

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Ingram Entertainment Inc. – Key Facts
Ingram Entertainment Inc. – Key Employees
Ingram Entertainment Inc. – Key Employee Biographies
Ingram Entertainment Inc. – Major Products and Services
Ingram Entertainment Inc. – History
Ingram Entertainment Inc. – Company Statement
Ingram Entertainment Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Business Unit
Section 2 – Company Analysis
Company Overview
Ingram Entertainment Inc. – Business Description
Ingram Entertainment Inc. – SWOT Analysis
SWOT Analysis – Overview
Ingram Entertainment Inc. – Strengths
Ingram Entertainment Inc. – Weaknesses
Ingram Entertainment Inc. – Opportunities
Ingram Entertainment Inc. – Threats
Ingram Entertainment Inc. – Key Competitors
Section 3 – Company’s Recent Developments
Jul 31, 2018: DBI Beverage announces top leadership changes, effective January 1, 2019
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Ingram Entertainment Inc., Key Facts
Ingram Entertainment Inc., Key Employees
Ingram Entertainment Inc., Key Employee Biographies
Ingram Entertainment Inc., Major Products and Services
Ingram Entertainment Inc., History
Ingram Entertainment Inc., Other Locations
Ingram Entertainment Inc., Affiliate
Ingram Entertainment Inc., Business Unit
Ingram Entertainment Inc., Key Competitors

★海外企業調査レポート[Ingram Entertainment Inc.:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cesca Therapeutics Inc. (KOOL):企業のM&A・提携動向(医療機器分野)
    Summary Cesca Therapeutics Inc. (Cesca) formerly ThermoGenesis Corp. is a medical equipment company. It researches, develops, and commercializes cell based therapeutics for application in regenerative medicine. Its lead technology platform, SurgWerks is used for the collection, separation, storage a …
  • Nextera AS:企業のM&A・提携動向(医療分野)
    Summary Nextera AS (Nextera) is a drug discovery company that concentrates on high-resolution target discovery and lead candidate development in HLA class II associated mechanisms. The company offers various approaches to improve therapeutic intervention of disease classes including autoimmune disea …
  • Staples, Inc.:企業のM&A・提携・投資分析
    Staples, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Staples, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Oxeia Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxeia Biopharmaceuticals Inc (Oxeia Biopharmaceuticals) is a clinical stage biotech company that develops drug treatments for mild traumatic brain injury or concussion and underlying neuro-metabolic dysfunction. The company’s lead pipeline candidate includes OXE-103, potent mitochondrial sta …
  • Barco N.V. (BAR):企業のM&A・提携動向(医療機器分野)
    Summary Barco N.V. (Barco) is a manufacturer of networked visualization products. It designs, develops and sells visualization solutions such as displays, workstations, monitors, image processors, LED displays, projectors, video walls, visual display systems, presentation and collaboration systems, …
  • Swissmed Centrum Zdrowia S.A. (SWD):企業の財務及び戦略的SWOT分析
    Summary Swissmed Centrum Zdrowia S.A. (Swissmed) is a medical organization that constructs and operates health care facilities. The company services include unlimited specialist care, laboratory tests, diagnostic examinations, nursing services and flu vaccination. Swissmed offers laboratory tests fo …
  • Bioaster-製薬・医療分野:企業M&A・提携分析
    Summary Bioaster is a technology research institute that conducts research on infectious diseases and microbiology. The institute offers services in the therapeutic areas of respiratory diseases, diarrhea, AIDS and tuberculosis. Its technologies include biological sample collections, genomics and tr …
  • Daisy Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Daisy Group plc Mergers and Acq …
  • DowDuPont Inc (DWDP):企業の財務・戦略的SWOT分析
    DowDuPont Inc (DWDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ImpediMed Limited (IPD):企業のM&A・提携動向(医療機器分野)
    Summary ImpediMed Limited (ImpediMed) designs, manufactures and sells bioimpedance spectroscopy (BIS) devices for assessing lymphoedema and body composition applications. The major products of the company include L-Dex U400 BIS device product to assess early signs of lymphedema; SFB7 single channel, …
  • Stellar Biotechnologies Inc (SBOT):企業の財務・戦略的SWOT分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • F-star Biotechnology Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …
  • Performance Food Group:企業の戦略・SWOT・財務情報
    Performance Food Group - Strategy, SWOT and Corporate Finance Report Summary Performance Food Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • National Buildings Construction Corporation Limited (NBCC):企業の財務及び戦略的SWOT分析
    Summary National Buildings Construction Corporation Limited (NBCC) is a construction company that offers project management consultancy, real estate development, and EPC contract services. The company’s projects include Womens Polytechnic, Solid Waste Management, NSIC Works, Defence Housing Project, …
  • Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Donaldson Company, Inc.:戦略・SWOT・企業財務分析
    Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Alpha Networks Inc. (3380):企業財務及び戦略的SWOT分析
    Summary Alpha Networks Inc. (Alpha Networks) is a network instruments manufacturer that designs, manufactures and markets network products. The company offers products in categories such as digital multimedia, LAN and MAN, mobile enterprise solutions, mobile and broadband, and wireless. Its mobile a …
  • Sezmi Corporation (formerly Building B, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sezmi Corporation (formerly Bui …
  • AB Science SA (AB):企業財務及び戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company that discovers, develops and commercializes tyrosine kinase inhibitor. The company concentrates its research on inflammatory diseases, cancers and central nervous system diseases in human and veterinary medicine. Its masitinib is an orally admi …
  • LEO Pharma AS:医療機器:M&Aディール及び事業提携情報
    Summary LEO Pharma A/S (LEO Pharma), a subsidiary of LEO Foundation is a research-based pharmaceutical company. It discovers, develops, manufactures and commercializes pharmaceuticals in therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆